The excerpts from The New Yorker (below) may be read as a companion piece to the Atlantic article profiling Dr. John Ioannidis. However, the opening example that Lehrer uses to make the point that initial impressive positive research findings often weaken . . . Continue reading →
Publication Bias
The Damaging Impact of PDUFA and Why It Should be Repealed
The re-prioritization of rapid approvals occurred at the expense of drug safety standards, Continue reading →
Reminder BBC Panorama-Secrets of the Drug Trial
The first in the BBC-Panorama series elicited more than 65,000 emails and phone calls.The fourth report aired tonight, focuses on study #329, the largest of the Paxil pediatric trials. BBC will show evidence of how the published report of this trial was . . . Continue reading →
NEJM- Caught Covering Up for National Kidney Foundation–an indudstry front group
Readers of the New England Journal of Medicine should be forewarned: The information in the pages of the NEJM is tainted by industry influence, its professional and scientific integrity are tainted. Continue reading →
Negative Research Results–Mostly Concealed in Journals_SharonBegley, WSJ
"Why are scientists coy about publishing negative data? Continue reading →
Article
The Evidence base: rock of certainty or shifting sands? – BMJ Wed, 5 May 2004 Dr. John Dewhurst, has written an extraordinary article from his first-hand experience as a pharmaceutical company physician who discovered the disparity that exists between the claimed and . . . Continue reading →
Int’l Registration of Clinical Research WHO
Int’l Registration of Clinical Research WHO Tue, 6 Apr 2004 On April 3, the World Health Organization (WHO) and Current Controlled Trials, Ltd (based in London, Philadelphia and Tokyo) announced that all randomized controlled clinical trials approved by the WHO ethics committee . . . Continue reading →
"Black Hole" of medical research–Negative Results Don’t get Published – JAMA, WSJ
“Black Hole” of medical research–Negative Results Don’t get Published – JAMA, WSJ Sat, 5 Jun 2004 “No one likes bad news. But in science, there is an ethical imperative to publish research, even if the findings aren’t what the researcher had hoped . . . Continue reading →
"Drug Companies Should Make Their Studies Public" NYT
“Drug Companies Should Make Their Studies Public” NYT Wed, 13 Aug 2003 Concealed and inaccessible research findings are undermining the integrity of medicine, the advancement of scientific knowledge, and most importantly, secrecy is putting people’s lives in jeopardy because prescribing doctors are . . . Continue reading →
British Psychiatrists Debate: "Clinical trials of antidepressant medications are producing meaningless results"
British Psychiatrists Debate: “Clinical trials of antidepressant medications are producing meaningless results” Wed, 27 Aug 2003 “The fact that most people support the psychopharmacological orthodoxy is, in itself, no argument and it is important to examine the evidence before drawing conclusions.” The . . . Continue reading →
Randomized Controlled Trials: Evidence Biased Psychiatry
Randomized Controlled Trials: Evidence Biased Psychiatry By David Healy, MD MRCPsych Introduction A new drug gets introduced to the market. It has been approved after stringent scrutiny by the FDA, which requires ever more convincing evidence that it works and that its . . . Continue reading →
Are SSRIs and Atypical Antidepressants Safe/ Effective for Children/ Adolescents/ Neonates?
Are SSRIs and Atypical Antidepressants Safe / Effective for Children / Adolescents/ Neonates? Wed, 2 Mar 2005 The American psychiatric establishment continues to operate within a “head in the sand” culture of denial when confronted with compelling evidence that has been scientifically . . . Continue reading →